Form 4: InspireMD CEO Marvin Slosman Reports Stock Transactions
SEC Form 4
CEO Marvin Slosman reports acquisition and disposal of InspireMD stock and stock options.
Summary
- On January 7, 2025, Marvin Slosman, CEO and President of InspireMD, Inc., reported transactions involving the company's stock.
- Slosman acquired 558,417 restricted stock units at $0, increasing his holdings to 2,410,536.
- He also acquired options to purchase 254,985 shares of common stock at an exercise price of $2.71, bringing his total option holdings to 937,796.
- The restricted stock units and options vest in three equal annual installments starting January 7, 2026, subject to continued service.
Sentiment
Score: 5
Explanation: Neutral sentiment as it's a standard disclosure of stock transactions by a company executive.
Positives
- The acquisition of restricted stock units and options could align the CEO's interests with those of the shareholders.
Future Outlook
The vesting of the restricted stock units and options is contingent upon the Reporting Person's continued service.
Industry Context
Form 4 filings are standard practice and provide transparency into the transactions of company insiders, allowing investors to monitor management's alignment with shareholder interests.
Stakeholder Impact
- Shareholders can monitor insider transactions to assess management's confidence in the company.
Key Dates
| Date | Description |
|---|---|
| 01/07/2025 | Date of transaction: Acquisition of restricted stock units and stock options. |
| 01/07/2026 | First vesting date for 1/3 of the restricted stock units and options. |
| 01/07/2027 | Second vesting date for 1/3 of the restricted stock units and options. |
| 01/07/2028 | Third vesting date for 1/3 of the restricted stock units and options. |
| 01/07/2035 | Expiration date for the options to purchase common stock. |
| 01/10/2025 | Date of signature for the report. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.